Our study documented high distribution of ESBLs among E. coli isolates from outpatients with recurrent UTIs, with CTX-M as the predominant ESBL. In the current situation, it is important that antibiotic treatment is be started only after a proper sensitivity report is obtained from the laboratory.
No takes yet. Share an insight, caveat, or question.
Al-Mayahie et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: